Kestra Medical Technologi...

NASDAQ: KMTS · Real-Time Price · USD
16.09
0.13 (0.81%)
At close: Aug 15, 2025, 3:59 PM
16.05
-0.25%
After-hours: Aug 15, 2025, 04:10 PM EDT

Kestra Medical Common Stock Income Statement

Financials in USD. Fiscal year is May - April.
Fiscal Year Q4 2024 Q3 2024 Q4 2023 Q3 2023 Q1 2021
Period Ending Apr 30, 2025 Jan 31, 2025 Apr 30, 2024 Jan 31, 2024 Jul 31, 2021
Revenue
17.23M 15.09M 10.05M 8.28M n/a
Cost of Revenue
9.6M 8.54M 8.66M 7.4M n/a
Gross Profit
7.63M 6.55M 1.4M 880K n/a
Operating Income
-48.21M -20.6M -20.35M -19.95M -12.29M
Interest Income
1.66M 628K n/a n/a n/a
Pretax Income
-51.01M -21.74M -22.31M -21.61M -13.08M
Net Income
-52.05M -21.51M -22.28M -21.62M -13.13M
Selling & General & Admin
50.46M 23.8M 17.93M 17.09M 7.43M
Research & Development
5.39M 3.35M 3.82M 3.73M 4.86M
Other Expenses
n/a n/a n/a n/a n/a
Operating Expenses
55.84M 27.15M 21.75M 20.83M 12.29M
Interest Expense
1.76M 1.78M 1.94M 1.65M 847K
Selling & Marketing Expenses
n/a n/a n/a n/a 7.43M
Cost & Expenses
65.44M 35.69M 30.4M 28.22M 12.29M
Income Tax Expense
102K 18K -27K 14K 57K
Shares Outstanding (Basic)
49.53M 49.53M 49.53M 49.53M 49.53M
Shares Outstanding (Diluted)
49.53M 49.53M 49.53M 49.53M 49.53M
EPS (Basic)
-2.21 -0.5 -0.45 -0.47 -0.27
EPS (Diluted)
-2.21 -0.5 -0.45 -0.47 -0.27
EBITDA
-47.41M -18.07M -16.87M -16.59M -12.15M
EBIT
-49.25M -19.96M -20.38M -19.95M -12.23M
Depreciation & Amortization
1.84M 1.89M 3.5M 3.36M 75K